Hepatitis B Vaccine Market Analysis
The Hepatitis B Vaccine Market, valued at USD 8.26 billion in 2023, is projected to grow to USD 11.84 billion by 2031. This growth reflects an emerging compound annual growth rate (CAGR) of 4.6% over the forecast period from 2024 to 2031.
Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV), and vaccination remains the most effective...
0 Commentarios
0 Acciones
681 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian